FN2 Earnings Intelligence
Zimmer Biomet Holdings, Inc. financials (quarterly)
Zimmer Biomet Holdings, Inc. (ZBH) Key Stats (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,384.5 | $556.9 | $1,292.7 | $424.2 | $410 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,909.1 | $2,077.3 | $2,001.4 | $2,086.7 | $2,177 | $2,040.1 | $2,293.3 |
| % Growth | - | - | - | - | - | 1.9% | - |
| Gross Profit | $1,359.3 | $1,485.1 | $1,442.1 | $1,510.5 | $1,541.5 | - | - |
| % Margin | 71.2% | 71.5% | 72.1% | 72.4% | 70.8% | - | - |
| EBITDA | $546.7 | $571.8 | $634.9 | $643.2 | $596.9 | - | - |
| % Margin | 28.6% | 27.5% | 31.7% | 30.8% | 27.4% | - | - |
| Net Income | $182 | $152.8 | $230.9 | $238.1 | $198.3 | - | - |
| % Margin | 9.5% | 7.4% | 11.5% | 11.4% | 9.1% | - | - |
| Diluted EPS | $0.91 | $0.77 | $1.16 | $1.22 | $1.03 | $1.88 | $2.49 |
| % Growth | - | - | - | - | - | 62.2% | - |
| Operating Cash Flow | $382.8 | - | - | $359.4 | - | - | - |
| CapEx | $44.6 | - | - | $36.3 | - | - | - |
| Free Cash Flow | $338.2 | - | - | $323.1 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,909.1 | $2,077.3 | $2,001.4 | $2,086.7 | $2,177 | $2,040.1 | $2,293.3 |
| Gross Profit | $1,359.3 | $1,485.1 | $1,442.1 | $1,510.5 | $1,541.5 | - | - |
| EBITDA | $546.7 | $571.8 | $634.9 | $643.2 | $596.9 | - | - |
| Net Income | $182 | $152.8 | $230.9 | $238.1 | $198.3 | - | - |
| Diluted EPS | $0.91 | $0.77 | $1.16 | $1.22 | $1.03 | $1.88 | $2.49 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,384.5 | $556.9 | $1,292.7 | $424.2 | $410 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $6,576.3 | $6,752.5 | $7,512.6 | $6,295.1 | $6,277.5 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $382.8 | - | - | $359.4 | - |
| Capital Expenditure | $44.6 | - | - | $36.3 | - |
| Free Cash Flow | $338.2 | - | - | $323.1 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 71.2% | 71.5% | 72.1% | 72.4% | 70.8% |
| EBITDA Margin | 28.6% | 27.5% | 31.7% | 30.8% | 27.4% |
| Net Margin | 9.5% | 7.4% | 11.5% | 11.4% | 9.1% |
| FCF Margin | 17.7% | - | - | 15.5% | - |
| Diluted EPS Growth | - | - | - | - | - |